With the advancement of medical treatments for childhood cancer, survival rates for pediatric cancer patients have increased significantly. As long-term survival rates increase, however, the neurocognitive deficits associated with particular types of treatments have become apparent.

A group of international attendees joined us on October 1, 2015 for an informative presentation delivered by Directors from the Dana Farber/Boston Children’s Cancer and Blood Disorder Center’s School Liaison Program. This webinar was designed to provide background information on the neurocognitive sequelae of pediatric cancer survivors and how these difficulties impact their educational experience. If you missed the webinar, you can view the recorded version by¬† clicking¬†here.